Home Package Inserts -Antibody-drug Conjugates

Package Inserts -Antibody-drug Conjugates

Year Approved**
Drug (INN)*Trade NameDeveloperFDAEurope
Gemtuzumab OzogamicinMaylotarg®Wyeth/Pfizer2000
(Witdrawn)		2000
(Witdrawn)
Gemtuzumab OzogamicinMaylotarg®Wyeth/Pfizer2017
(Reintroduced)
Brentuximab VedodinAdcetris®Seattle Genetics / Takeda20112012
Ado-trastuzumab emtansineKadcyla®Genentech/Roche20132013
Inotuzumab OzogamicinBesponsa®Wyeth/Pfizer20172017
Polatuzumab vedotin-piiq
Polivy™Genentech/Roche2019

* Link to drug description
** Link to package insert

ADC Bio
Lonza
MabPlex
ADC Review, Journal of Antibody-drug Conjugates
MADE POSSIBLE BY:
ADCBIO
Lonza
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policy makers.

Latest

Peer Review

© 2013-2019 Sunvalley Communication, LLC. All Rights Reserved.